Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Dry Eye Syndrome Market 2015-2019

Dry eye syndrome usually results in dryness of eyes due to deficient tear production or quick tear evaporation or deviation in tear uniformity. This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye. Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity. Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment. The analysts forecast global dry eye syndrome market to grow at a CAGR of 4.75......
$2500

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019

Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death. The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal ......
$2500

Global Vitamin B-complex Ingredients Market 2015-2019

Vitamins are organic compounds that are required by living organisms in minute quantities to maintain a normal metabolic activity. These compounds usually cannot be synthesized by the organism and have to be obtained through external sources. The term "vitamin" is a generic descriptor for a group of chemical compounds or ingredients that have similar molecular structure and have the capability to perform the required vitamin-activity. These chemical compounds or vitamin ingredients are often called as vitamers. There are thirteen different known types of vitamins with each type having multiple vitamers. Vitamin B-complex refers to a group of water-soluble vitamers that although co-exist together are distinct in chemical structure and functions. The demand for vitamins, and particular......
$3000

Global Human Insulin Market 2015-2019

Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin c......
$2500

Global Hyperphosphatemia Drugs Market 2015-2019

Phosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and al......
$2500

Global Medical Billing Outsourcing Market 2015-2019

Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequality in availability of patient care. Over the years, healthcare enterprises worldwide have become increasingly dependent on technology and the Internet for their day to day operations. This trend is expected to intensify, which will make the role of IT departments vital. However, many healthcare enterprises are facing difficulties in handling medical operations, and managing and providing healthcare services to their customers. Inc......
$2500

Global Medical Transcription Market 2015-2019

Medical transcription is the process that involves documentation of medical records from voice to text format. Physicians record patient details in audio format, and these details are sent to a transcriptionist to decode and store in digital format. Medical transcription helps make data interpretation and analysis easy as through this health records are stored in a structured format. With the adoption of new technology and improvements in the healthcare sector, the global medical transcription market is expected to experience various opportunities. The analysts forecast global medical transcription market to grow at a CAGR of 6% over the period 2014-2019. Covered in this report The report covers the present scenario and the growth prospects of the global medical transcription mark......
$2000

Global Membrane Market in Pharmaceutical Industry 2015-2019

Membranes are a type of selective barrier that are primarily used for separation or concentration of the feed stream. The feed stream is passed through the membrane that selectively allows some constituents to pass, while others are retained back on the surface of the membrane, depending on its pore size. The constituents that are allowed to pass are known as permeate and the ones retained back are known as concentrate or retentate. Different types of membrane are used in the pharmaceutical industry depending on their pore size. There are many technologies implemented for these membranes, including ultrafiltration, microfiltration, reverse osmosis, and nanofiltration. Other membrane technologies, such as membrane contractors, electrodialysis, and pervaporation are also used, but their m......
$3000

Connected Health M2M Market in the US 2015-2019

Connected health M2M is a remote healthcare service delivery model that functions in an IT ecosystem. It enables the accessing and sharing of healthcare information and the analysis of healthcare data. It provides the management of clinical data, and communication and collaboration among all the stakeholders of the healthcare service ecosystem. Some of its major functions are home monitoring, clinical monitoring, telemedicine, first responder connectivity, connected medical environment, clinical remote monitoring, assisted living and clinical trials, and healthcare asset management. The analysts forecast connected health M2M market in the US to grow at a CAGR of 28.72% over the period 2015-2019. Covered in this Report The report, Connected Health M2M Market in the US 2015-2019, ha......
$2500

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019

CINV is one of the most dreaded adverse effects of chemotherapy. It often leads to the postponement or refusal of potentially curative chemotherapy treatment for cancer. This nausea and vomiting, associated with chemotherapy regimen, affects the quality of life of an individual. The neurotransmitters in CINV are dopamine, 5-HT3, substance P, and endocannabinoids. CINV can be caused by the stimulation of vomiting center by the abdominal vagal afferents or by the direct stimulation of CTZ in the area postrema. The risk of development of CINV changes with the use of different types of chemotherapy regimens such as high, moderate, low, and minimal risk. Based on the type of CINV, different treatment regimens are prescribed. The classes of drugs used in the treatment of CINV are 5-HT3 rec......
$2500